Compare MIDD & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIDD | GRFS |
|---|---|---|
| Founded | 1888 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.5B |
| IPO Year | 1995 | N/A |
| Metric | MIDD | GRFS |
|---|---|---|
| Price | $142.28 | $8.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $180.13 | $10.15 |
| AVG Volume (30 Days) | 533.3K | ★ 551.2K |
| Earning Date | 05-08-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,201,202,000.00 | N/A |
| Revenue This Year | $5.87 | $4.49 |
| Revenue Next Year | $3.22 | $6.42 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $110.82 | $7.09 |
| 52 Week High | $169.44 | $11.14 |
| Indicator | MIDD | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 54.63 |
| Support Level | $128.74 | $8.27 |
| Resistance Level | $148.33 | $8.88 |
| Average True Range (ATR) | 4.26 | 0.19 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 55.41 | 56.25 |
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.